edelfosine and tanespimycin

edelfosine has been researched along with tanespimycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mollinedo, F; Mollinedo-Gajate, C; Muro, A; Varela-M, RE	1

Other Studies

1 other study(ies) available for edelfosine and tanespimycin

Article	Year
The HSP90 inhibitor 17-AAG potentiates the antileishmanial activity of the ether lipid edelfosine. Acta tropica, 2014, Volume: 131 Topics: Apoptosis; Benzoquinones; Culture Media; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G1 Phase Cell Cycle Checkpoints; Gene Expression; HSP90 Heat-Shock Proteins; Lactams, Macrocyclic; Leishmania; Leishmania infantum; Phospholipid Ethers; Protozoan Proteins; Resting Phase, Cell Cycle	2014

Article

Year

The HSP90 inhibitor 17-AAG potentiates the antileishmanial activity of the ether lipid edelfosine.

Acta tropica, 2014, Volume: 131

Topics: Apoptosis; Benzoquinones; Culture Media; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G1 Phase Cell Cycle Checkpoints; Gene Expression; HSP90 Heat-Shock Proteins; Lactams, Macrocyclic; Leishmania; Leishmania infantum; Phospholipid Ethers; Protozoan Proteins; Resting Phase, Cell Cycle

2014